Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.

Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid sy...

Full description

Bibliographic Details
Main Authors: Anna C Jones, Kresta S Antillon, Shannon M Jenkins, Sara N Janos, Heidi N Overton, Dor S Shoshan, Edgar G Fischer, Kristina A Trujillo, Marco Bisoffi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4358924?pdf=render
id doaj-700822ad8eb147b492580151c2a048af
record_format Article
spelling doaj-700822ad8eb147b492580151c2a048af2020-11-25T02:32:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011931410.1371/journal.pone.0119314Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.Anna C JonesKresta S AntillonShannon M JenkinsSara N JanosHeidi N OvertonDor S ShoshanEdgar G FischerKristina A TrujilloMarco BisoffiProstate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p<0.0001 to p = 0.08 and p<0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p<0.0001 to p<0.05 and p<0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p<0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p<0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter- and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins.http://europepmc.org/articles/PMC4358924?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Anna C Jones
Kresta S Antillon
Shannon M Jenkins
Sara N Janos
Heidi N Overton
Dor S Shoshan
Edgar G Fischer
Kristina A Trujillo
Marco Bisoffi
spellingShingle Anna C Jones
Kresta S Antillon
Shannon M Jenkins
Sara N Janos
Heidi N Overton
Dor S Shoshan
Edgar G Fischer
Kristina A Trujillo
Marco Bisoffi
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
PLoS ONE
author_facet Anna C Jones
Kresta S Antillon
Shannon M Jenkins
Sara N Janos
Heidi N Overton
Dor S Shoshan
Edgar G Fischer
Kristina A Trujillo
Marco Bisoffi
author_sort Anna C Jones
title Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
title_short Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
title_full Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
title_fullStr Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
title_full_unstemmed Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
title_sort prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (mic-1) and platelet derived growth factor a (pdgf-a) in tumor adjacent tissue.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p<0.0001 to p = 0.08 and p<0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p<0.0001 to p<0.05 and p<0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p<0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p<0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter- and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins.
url http://europepmc.org/articles/PMC4358924?pdf=render
work_keys_str_mv AT annacjones prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT krestasantillon prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT shannonmjenkins prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT saranjanos prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT heidinoverton prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT dorsshoshan prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT edgargfischer prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT kristinaatrujillo prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
AT marcobisoffi prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue
_version_ 1724820542321590272